John Cunningham (JC) Virus Encephalitis Without Progressive Multifocal Leukoencephalopathy in a Stem Cell Transplant Patient: A Case Report and Literature Review
- PMID: 40772164
- PMCID: PMC12327955
- DOI: 10.7759/cureus.87464
John Cunningham (JC) Virus Encephalitis Without Progressive Multifocal Leukoencephalopathy in a Stem Cell Transplant Patient: A Case Report and Literature Review
Abstract
John Cunningham (JC) Virus (JCV) belongs to the Polyomaviridae family and is notorious for remaining latent in the kidneys and lymphoid organs of healthy populations. However, in the setting of profound immunosuppression, the virus can reactivate, leading to various manifestations depending on its location of infection, i.e., progressive multifocal leukoencephalopathy (PML), JC virus encephalopathy, or JC virus granule cell neuronopathy. Here, we present a unique case of a 28-year-old female with a notable medical history of acute myeloid leukemia (AML) status post stem cell transplant who presented to the emergency department (ED) for evaluation of her altered mental status for one week. Laboratory investigations documented the presence of JCV in both the blood and cerebrospinal fluid (CSF). Unlike the typical findings of PML, the brain imaging revealed a 4 mm T2-weighted fluid attenuated inversion recovery (T2/FLAIR) hyperintense enhancing focus in the right supratentorial region and a right anterior temporal subcortical white matter enhancement measuring up to 14 mm in size with no corresponding FLAIR abnormality suggestive of JCV encephalitis. The patient received virus-specific T cells but showed minimal to no improvement. Hence, the patient's family opted for hospice care, but the patient died subsequently. JCV encephalitis is a relatively rare condition; only a few case reports have been reported. The prognosis of JCV encephalitis is not well established and is most often lethal with high viral loads. Virus-specific T-cell therapy has not yet demonstrated the desired clinical benefit; therefore, additional data are required.
Keywords: acute myeloid leukemia; encephalitis; jc virus; progressive multifocal leukoencephalopathy; stem cell.
Copyright © 2025, Fatima et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.Epidemiol Health. 2018 Jan 5;40:e2018001. doi: 10.4178/epih.e2018001. eCollection 2018. Epidemiol Health. 2018. PMID: 29370683 Free PMC article.
-
Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review.Neurol Sci. 2023 Sep;44(9):2995-2998. doi: 10.1007/s10072-023-06944-0. Epub 2023 Jul 8. Neurol Sci. 2023. PMID: 37421487
-
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers.Viruses. 2025 Jun 30;17(7):934. doi: 10.3390/v17070934. Viruses. 2025. PMID: 40733551 Free PMC article.
-
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients.Acta Neuropathol Commun. 2025 May 19;13(1):106. doi: 10.1186/s40478-025-02027-7. Acta Neuropathol Commun. 2025. PMID: 40390121 Free PMC article.
-
Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification.J Neurol Sci. 2024 Jun 15;461:123046. doi: 10.1016/j.jns.2024.123046. Epub 2024 May 12. J Neurol Sci. 2024. PMID: 38761670
References
-
- Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Padgett B, Zurhein G, Walker D, Eckroade R, Dessel B. Lancet. 1971;297:1257–1260. - PubMed
-
- Progressive multifocal leukoencephalopathy: why gray and white matter. Gheuens S, Wüthrich C, Koralnik IJ. Annu Rev Pathol. 2013;8:189–215. - PubMed
-
- Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005. Christensen KL, Holman RC, Hammett TA, Belay ED, Schonberger LB. Neuroepidemiology. 2010;35:178–184. - PubMed
Publication types
LinkOut - more resources
Full Text Sources